SARASOTA, Fla., May 16, 2024 (GLOBE NEWSWIRE) — Oragenics, Inc. (NYSE American: OGEN), a pioneering pharmaceutical company specializing in intranasal […]
Continued execution across Ampligen® clinical development programs and growing body of positive data in multiple high-value indications Company to host […]